Sri Lanka’s Brandix i3 in collaboration with US-based- Mayo Clinic on Monday officially announced the commercialisation of the Mortality Review System – a web based computer application that aggregates hospital process of care and system failures identified during a review process and analyses the causes of death among hospital patients. Inpatient mortality is receiving increasing [...]

The Sundaytimes Sri Lanka

Brandix i3 signs agreement with Mayo Clinic to launch the Mortality Review System

View(s):

Sri Lanka’s Brandix i3 in collaboration with US-based- Mayo Clinic on Monday officially announced the commercialisation of the Mortality Review System – a web based computer application that aggregates hospital process of care and system failures identified during a review process and analyses the causes of death among hospital patients.

Inpatient mortality is receiving increasing scrutiny. A US Senate hearing in July 2014, noted that the sheer number of deaths in US hospitals is often overlooked.

Mortality Review System (MRS) is a mixed method (qualitative and quantitative) approach to review the care provided preceding patients’ hospital deaths. The MRS combines both process improvement methodologies and software. The software component manages the workflow associated with interdisciplinary review of care delivered preceding death. MRS reconciles reviewers’ differing findings, compiles root process of care failures as key quantitative indicators and trends findings to identify opportunities for prevention of future unwarranted deaths, according to the Brandix media release.

Brandix i3 has licensed the Mortality Review System from Mayo Clinic, which has been using the software component successfully since 2007 to document and learn from their 100 per cent mortality review.

Commenting on the commercialisation of the Mortality Review System, Chief Executive Officer of Brandix i3, Arjuna Sirinanda said, “We have worked in collaboration with Mayo Clinic to offer MRS – a web based tool that has been successfully internalised at Mayo Clinic with proven results. MRS is an effective way for healthcare providers to significantly reduce mortality rates and provide better patient care services.”

“Brandix i3 will make the product available to other healthcare institutions,” said the Associate Vice President – Healthcare at Brandix i3, Aaron Epps. Further, he added, “These are exciting times for the healthcare industry in the US and as a company, we will continue to bring healthcare informatics solutions to providers in order to facilitate meaningful change in the industry.”

Share This Post

DeliciousDiggGoogleStumbleuponRedditTechnoratiYahooBloggerMyspace

Advertising Rates

Please contact the advertising office on 011 - 2479521 for the advertising rates.